Putting a little structure in your drug design

摘要

The value of Structure Based Drug Design (SBDD) in the drug discovery process was recently highlighted in work by UCB and Domainex1 which led to the successful discovery of novel inhibitors of Mitogen-activated protein kinase kinase (MAPKK, also known as MEK), which is over-active in many human cancers.